Robert Wasserman

Q: What is Robert Wasserman's success rate?

Robert Wasserman currently has a success rate of 83.941210830502.

Q: What is the average return of Robert Wasserman's calls?

Their stock ratings have generated an average return of 146.56538827686103.

Benchmark | Healthcare

Robert Wasserman is an analyst from Benchmark specializing in the Healthcare sector. Ranked #35 out of 4548 analysts, they have issued 12 stock ratings with a success rate of 83.94% and an average return of 146.57%.

With 12 ratings to date, Robert Wasserman is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 83.94% and an average return of 146.57%, highlighting promising potential as their track record develops further.

#35

Out of 4548

Total Ratings

+83.94%

Success Rate

+146.57%

Average Return

Recent Ratings Analysis

ITGR

Buy

Feb 20, 2026

Target

$95.00

Current

$84.85

Performance

0.00%

Robert Wasserman rated ITGR as Buy on Feb 20, 2026, setting a price target of 95. Shares have remained stable near 84.85, leaving the 95 target still in play.

HALO

Buy

Feb 19, 2026

Target

$90.00

Current

$70.98

Performance

-1.47%

On Feb 19, 2026, HALO was given a Buy rating by Robert Wasserman, with a target price of 90. The stock traded sideways with a -1.47% move, keeping the bullish thesis unresolved.

LGND

Buy

Nov 07, 2025

Target

$220.00

Current

$183.98

Performance

-9.14%

LGND received a Buy rating from Robert Wasserman on Nov 07, 2025, aiming for 220. The rating hasn’t played out as hoped, with the stock trading 9.14% below expectations.

PRLB

Buy

Nov 03, 2025

Target

$55.00

Current

$65.37

Performance

22.26%

On Nov 03, 2025, Robert Wasserman published a Buy outlook on PRLB, with a target of 55. Shares gained 22.26%, underscoring the accuracy of the bullish outlook toward 55.

INTS

Buy

Aug 20, 2025

Target

$1.50

Current

$5.86

Performance

-21.87%

Robert Wasserman on Aug 20, 2025 assigned INTS a Speculative Buy rating, with a price target of 1.5. The call has struggled to gain traction, with shares losing 21.87%.

IPA

Buy

Apr 01, 2025

Target

$3.00

Current

$1.62

Performance

349.38%

On Apr 01, 2025, Robert Wasserman reaffirmed IPA with a Speculative Buy rating, targeting 3. The recommendation was supported by strong follow-through as the stock rose from 1.62 to 1.62.

KMDA

Buy

Mar 21, 2025

Target

$15.00

Current

$8.80

Performance

30.95%

KMDA was rated Buy by Robert Wasserman on Mar 21, 2025, with a price objective of 15. A bullish response from the market helped close the gap of 6.20 to the target.

OABI

Buy

Mar 20, 2025

Target

$6.00

Current

$1.70

Performance

-25.11%

On Mar 20, 2025, Robert Wasserman initiated coverage on OABI with a Buy rating and target of 6. The Buy call has yet to be validated as shares remain 4.30 away from the target.

ABCL

Hold

Mar 03, 2025

Target

$0.00

Current

$3.04

Performance

28.81%

Robert Wasserman issued a Hold recommendation for ABCL on Mar 03, 2025, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

BLFS

Buy

Dec 19, 2024

Target

$30.00

Current

$23.09

Performance

-11.57%

On Dec 19, 2024, BLFS was evaluated by Robert Wasserman, who gave a Buy rating and target of 30. Investors saw limited payoff as shares fell short of the 30 target.

ANEB

Buy

Nov 19, 2024

Target

$8.00

Current

$0.47

Performance

-68.88%

Robert Wasserman rated ANEB as Speculative Buy on Nov 19, 2024, setting a price target of 8. The stock has underperformed, dropping 68.88% despite the bullish target of 8.

CDXS

Hold

Aug 19, 2024

Target

$0.00

Current

$1.17

Performance

-61.13%

On Aug 19, 2024, CDXS was given a Hold rating by Robert Wasserman, with a target price of null. The rating provided protection from downside risk as the stock fell to 1.17.

EBS

Buy

Aug 16, 2024

Target

$8.00

Current

$10.93

Performance

1.77%

EBS received a Buy rating from Robert Wasserman on Aug 16, 2024, aiming for 8. Price action was muted, as shares hovered around 10.93 despite the bullish outlook.

TECH

Buy

May 02, 2024

Target

$95.00

Current

$57.52

Performance

-23.92%

On May 02, 2024, Robert Wasserman published a Buy outlook on TECH, with a target of 95. Market action contradicted the Buy thesis, as shares slipped to 57.52.

NEPH

Buy

Mar 08, 2024

Target

$5.00

Current

$4.08

Performance

51.11%

Robert Wasserman on Mar 08, 2024 assigned NEPH a Speculative Buy rating, with a price target of 5. The Buy call aligned well with market performance, producing a gain of 51.11%.

Frequency Asked Questions

Who is Robert Wasserman?

Robert Wasserman is an analyst from Benchmark specializing in the Healthcare sector.

What is Robert Wasserman's success rate?

Robert Wasserman currently has a success rate of +83.94%.

How many ratings has Robert Wasserman issued?

Robert Wasserman has issued 12 stock ratings so far.

What is the average return of Robert Wasserman's calls?

Their stock ratings have generated an average return of +146.57%.

What is Robert Wasserman's ranking?

Robert Wasserman is ranked #35 out of 4548 analysts.

What types of ratings does Robert Wasserman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Robert Wasserman?

You can follow Robert Wasserman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Robert Wasserman?

Their latest rating was a Buy on ITGR issued on 2026-02-20.